Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,146 public trials 1,794 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Recruiting

Deep Learning on Amyloid Positons Emission Tomography

NCT07309107

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • CHRU NANCY Brabois, nuclear medicine department Vandœuvre-lès-Nancy, France
  • Nancy's hospital Vandœuvre-lès-Nancy, France
  • Nuclear medicine department CHRU de NANCY Brabois Vandœuvre-lès-Nancy, France
View Trial Details
Recruiting

Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

NCT06891443

Conditions
Blindness, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +28 more
Locations
  • UCSF Wayne and Gladys Valley Center for Vision San Francisco, California, United States
  • University of Miami - Bascom Palmer Eye Institute Miami, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Minnesota Medical School Minneapolis, Minnesota, United States
View all 17 locations
View Trial Details
Recruiting

TSC Biosample Repository and Natural History Database

NCT05676099

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Loma Linda University Children's Hospital Loma Linda, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center Oakland, California, United States
View all 26 locations
View Trial Details
Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

NCT06993844

Conditions
Adnexal Diseases, Advanced Breast Cancer, Advanced Solid Tumors, +40 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Recruiting

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT07190300

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Uni Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • Wichita Urology Group PA Wichita, Kansas, United States
View all 31 locations
View Trial Details

Related conditions